Order Article Reprints

Bonanad C, Raposeiras-Roubin S, García-Blas S, Núñez-Gil I, Vergara-Uzcategui C, Díez-Villanueva P, Bañeras J, Badía Molins C, Aboal J, Carreras J, et al. Evaluation of the Use of Dual Antiplatelet Therapy beyond the First Year after Acute Coronary Syndrome. Journal of Clinical Medicine. 2022; 11(6):1680. https://doi.org/10.3390/jcm11061680

Bonanad, Clara, Sergio Raposeiras-Roubin, Sergio García-Blas, Iván Núñez-Gil, Carlos Vergara-Uzcategui, Pablo Díez-Villanueva, Jordi Bañeras, Clara Badía Molins, Jaime Aboal, Jose Carreras, and et al. 2022. "Evaluation of the Use of Dual Antiplatelet Therapy beyond the First Year after Acute Coronary Syndrome" Journal of Clinical Medicine 11, no. 6: 1680. https://doi.org/10.3390/jcm11061680

Bonanad, C., Raposeiras-Roubin, S., García-Blas, S., Núñez-Gil, I., Vergara-Uzcategui, C., Díez-Villanueva, P., Bañeras, J., Badía Molins, C., Aboal, J., Carreras, J., Bodi, V., Gabaldón-Pérez, A., Mateus-Porta, G., Parada Barcia, J. A., Martínez-Sellés, M., Chorro, F. J., & Ariza-Solé, A. (2022). Evaluation of the Use of Dual Antiplatelet Therapy beyond the First Year after Acute Coronary Syndrome. Journal of Clinical Medicine, 11(6), 1680. https://doi.org/10.3390/jcm11061680